When surveyed by the agency on November 12, Yuheng Pharmaceutical said that the company's core products have basically entered the collection catalogue of national/provincial alliances. There is a certain cycle of collection, and sales of collected products are expected to remain stable or grow in the future. Currently, the impact of the collection policy on the company's overall performance is relatively limited.

When surveyed by the agency on November 12, Yuheng Pharmaceutical said that the company's core products have basically entered the collection catalogue of national/provincial alliances. There is a certain cycle of collection, and sales of collected products are expected to remain stable or grow in the future. Currently, the impact of the collection policy on the company's overall performance is relatively limited.